{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T21:32:19Z","timestamp":1789594339778,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T00:00:00Z","timestamp":1562284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11920-019-1047-7","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T07:25:11Z","timestamp":1562311511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Management of Late-Life Depression in the Context of Cognitive Impairment: a Review of the Recent Literature"],"prefix":"10.1007","volume":"21","author":[{"given":"Kathleen S.","family":"Bingham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair J.","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit H.","family":"Mulsant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,5]]},"reference":[{"key":"1047_CR1","doi-asserted-by":"crossref","unstructured":"Diagnostic and statistical manual of mental disorders. 5th ed. American Psychiatric Association; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"1047_CR2","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/01.JGP.0000203130.45421.69","volume":"14","author":"RK Bhalla","year":"2006","unstructured":"Bhalla RK, Butters MA, Mulsant BH, Begley AE, Zmuda MD, Schoderbek B, et al. Persistence of neuropsychologic deficits in the remitted state of late-life depression. Am J Geriatr Psychiatry. 2006;14:419\u201327.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1047_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/archpsyc.61.6.587","volume":"61","author":"MA Butters","year":"2004","unstructured":"Butters MA, Whyte EM, Nebes RD, Begley AE, Dew MA, Mulsant BH, et al. The nature and determinants of neuropsychological functioning in late-life depression. Arch Gen Psychiatry. 2004;61:587\u201395.","journal-title":"Arch Gen Psychiatry"},{"key":"1047_CR4","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.cger.2014.05.002","volume":"30","author":"BH Mulsant","year":"2014","unstructured":"Mulsant BH, Blumberger DM, Ismail Z, Rabheru K, Rapoport MJ. A systematic approach to the pharmacotherapy of geriatric major depression. Clin Geriatr Med. 2014;30:517\u201334.","journal-title":"Clin Geriatr Med"},{"key":"1047_CR5","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Orgeta V, Qazi A, Spector A, Orrell M. Psychological treatments for depression and anxiety in dementia and mild cognitive impairment: systematic review and meta-analysis. Br J Psychiatry. 2015;207:293\u20138. This is the main meta-analysis investigating structured psychological treatments (e.g. cognitive behavioral therapy) for depression and depressive symptoms in neurocognitive disorders.","DOI":"10.1192\/bjp.bp.114.148130"},{"key":"1047_CR6","first-page":"CD012279","volume":"3","author":"NJ Gates","year":"2019","unstructured":"Gates NJ, Vernooij RW, Di Nisio M, Karim S, March E, Mart\u00ednez G, et al. Computerised cognitive training for preventing dementia in people with mild cognitive impairment. Cochrane Database Syst Rev. 2019;3:CD012279.","journal-title":"Cochrane Database Syst Rev"},{"key":"1047_CR7","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Dudas R, Malouf R, McCleery J, Dening T. Antidepressants for treating depression in dementia. Cochrane database of systematic reviews [internet]. 2018 [cited 2018 Dec 12]; available from: \n                      https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003944.pub2\/abstract\n                      \n                    . This is the most recent Cochrane meta-analysis investigating the efficacy and tolerability of antidepressant medication for treating depressive disorders in dementia.","DOI":"10.1002\/14651858.CD003944.pub2"},{"issue":"6","key":"1047_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40266-018-0546-2","volume":"35","author":"Ane Erdal","year":"2018","unstructured":"Erdal A, Flo E, Aarsland D, Ballard C, Slettebo DD, Husebo BS. Efficacy and safety of analgesic treatment for depression in people with advanced dementia: randomised, multicentre, double-blind, placebo-controlled trial (DEP.PAIN.DEM). Drugs Aging 2018;35:545\u2013558.","journal-title":"Drugs & Aging"},{"key":"1047_CR9","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.2147\/CIA.S165224","volume":"13","author":"K Konis","year":"2018","unstructured":"Konis K, Mack WJ, Schneider EL. Pilot study to examine the effects of indoor daylight exposure on depression and other neuropsychiatric symptoms in people living with dementia in long-term care communities. Clin Interv Aging. 2018;13:1071\u20137.","journal-title":"Clin Interv Aging"},{"key":"1047_CR10","first-page":"CD003477","volume":"7","author":"JT van der Steen","year":"2018","unstructured":"van der Steen JT, Smaling HJ, van der Wouden JC, Bruinsma MS, Scholten RJ, Vink AC. Music-based therapeutic interventions for people with dementia. Cochrane Database Syst Rev. 2018;7:CD003477.","journal-title":"Cochrane Database Syst Rev"},{"key":"1047_CR11","doi-asserted-by":"publisher","unstructured":"Woods B, O\u2019Philbin L, Farrell EM, Spector AE, Orrell M. Reminiscence therapy for dementia. Cochrane database of systematic reviews [internet]. 2018 [cited 2019 Apr 8]; Available from: \n                      https:\/\/doi.org\/10.1002\/14651858.CD001120.pub3","DOI":"10.1002\/14651858.CD001120.pub3"},{"key":"1047_CR12","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3233\/JAD-160225","volume":"55","author":"H An","year":"2017","unstructured":"An H, Choi B, Park K-W, Kim D-H, Yang D-W, Hong CH, et al. The effect of escitalopram on mood and cognition in depressive Alzheimer\u2019s disease subjects. J Alzheimers Dis. 2017;55:727\u201335.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1047_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3233\/JAD-161247","volume":"58","author":"Vasiliki Orgeta","year":"2017","unstructured":"\u2022 Orgeta V, Tabet N, Nilforooshan R, Howard R. Efficacy of antidepressants for depression in Alzheimer\u2019s disease: systematic review and meta-analysis. [review]. J Alzheimer. 2017;58:725\u201333. This meta-analysis examines antidepressant medication for depression and depressive symptoms in Alzheimer\u2019s disease specifically.","journal-title":"Journal of Alzheimer's Disease"},{"key":"1047_CR14","doi-asserted-by":"publisher","unstructured":"Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A. Omega-3 fatty acids for the treatment of dementia. Cochrane Database of Systematic Reviews [Internet]. 2016 [cited 2019 Apr 8]; Available from: \n                      https:\/\/doi.org\/10.1002\/14651858.CD009002.pub3\/full","DOI":"10.1002\/14651858.CD009002.pub3\/full"},{"key":"1047_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jagp.2015.07.010","volume":"24","author":"KA Gustavson","year":"2016","unstructured":"Gustavson KA, Alexopoulos GS, Niu GC, McCulloch C, Meade T, Are\u00e1n PA. Problem-solving therapy reduces suicidal ideation in depressed older adults with executive dysfunction. Am J Geriatr Psychiatry. 2016;24:11\u20137.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1047_CR16","doi-asserted-by":"publisher","first-page":"P310","DOI":"10.1016\/j.jalz.2016.06.562","volume":"12","author":"E Larouche","year":"2016","unstructured":"Larouche E, Chouinard A-M, Goulet S, Hudon C. Mindfulness-based intervention prevents memory decline and improves mood and quality of life in older adults with mild cognitive impairment: preliminary findings. Alzheimer\u2019s Dement: J Alzheimer\u2019s Assoc. 2016;12:P310.","journal-title":"Alzheimer\u2019s Dement: J Alzheimer\u2019s Assoc"},{"key":"1047_CR17","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/gps.4436","volume":"31","author":"C Olsen","year":"2016","unstructured":"Olsen C, Pedersen I, Bergland A, Enders-Slegers M-J, Patil G, Ihlebaek C. Effect of animal-assisted interventions on depression, agitation and quality of life in nursing home residents suffering from cognitive impairment or dementia: a cluster randomized controlled trial. Int J Geriatr Psychiatry. 2016;31:1312\u201321.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1047_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1080\/01612840.2016.1183736","volume":"37","author":"LL Onega","year":"2016","unstructured":"Onega LL, Pierce TW, Epperly L. Effect of bright light exposure on depression and agitation in older adults with dementia. Issues Ment Health Nurs. 2016;37:660\u20137.","journal-title":"Issues Ment Health Nurs"},{"key":"1047_CR19","doi-asserted-by":"publisher","unstructured":"Forbes D, Forbes SC, Blake CM, Thiessen EJ, Forbes S. Exercise programs for people with dementia. Cochrane database of systematic reviews [internet]. 2015 [cited 2019 Apr 14]; Available from: \n                      https:\/\/doi.org\/10.1002\/14651858.CD006489.pub4\/full?highlightAbstract=withdrawn%7Cdementia%7Cdementi%7Cdepress%7Cdepression\n                      \n                    .","DOI":"10.1002\/14651858.CD006489.pub4\/full?highlightAbstract=withdrawn%7Cdementia%7Cdementi%7Cdepress%7Cdepression"},{"issue":"1","key":"1047_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1001\/jamapsychiatry.2014.1305","volume":"72","author":"Dimitris N. Kiosses","year":"2015","unstructured":"\u2022 Kiosses DN, Ravdin LD, Gross JJ, Raue P, Kotbi N, Alexopoulos GS. Problem adaptation therapy for older adults with major depression and cognitive impairment: a randomized clinical trial. JAMA Psychiatry. 2015;72:22\u201330. This high-quality study demonstrated the efficacy of Problem Adaptation Therapy (PATH) in treating depression in MCI and dementia. It provides a description of the PATH model in Table 1.","journal-title":"JAMA Psychiatry"},{"key":"1047_CR21","doi-asserted-by":"crossref","unstructured":"\u2022 Olin JT, Katz IR, Meyers BS, Schneider LS, Lebowitz BD. Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background. [Review] [128 refs][Erratum appears in Am J Geriatr Psychiatry 2002 May-Jun;10(3):264]. J Geriatric Psychiatry. 2002;10:129\u201341. This is the manuscript that describes the development of the proposed NIMH criteria for the diagnosis of depression in Alzheimer\u2019s disease; referred to as Olin\u2019s criteria and NIMH-dAD.","DOI":"10.1097\/00019442-200203000-00004"},{"key":"1047_CR22","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","volume":"63","author":"Y Freund-Levi","year":"2006","unstructured":"Freund-Levi Y, Eriksdotter-J\u00f6nhagen M, Cederholm T, Basun H, Fax\u00e9n-Irving G, Garlind A, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63:1402\u20138.","journal-title":"Arch Neurol"},{"key":"1047_CR23","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3233\/JAD-150200","volume":"48","author":"DN Kiosses","year":"2015","unstructured":"Kiosses DN, Rosenberg PB, McGovern A, Fonzetti P, Zaydens H, Alexopoulos GS. Depression and suicidal ideation during two psychosocial treatments in older adults with major depression and dementia. J Alzheimer. 2015;48:453\u201362.","journal-title":"J Alzheimer"},{"key":"1047_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archgenpsychiatry.2010.177","volume":"68","author":"GS Alexopoulos","year":"2011","unstructured":"Alexopoulos GS, Raue PJ, Kiosses DN, Mackin RS, Kanellopoulos D, McCulloch C, et al. Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction: effect on disability. Arch Gen Psychiatry. 2011;68:33\u201341.","journal-title":"Arch Gen Psychiatry"},{"key":"1047_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta17070","volume":"17","author":"S Banerjee","year":"2013","unstructured":"Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, et al. Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine. Health Technol Assess. 2013;17:1\u2013166.","journal-title":"Health Technol Assess"},{"key":"1047_CR26","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000102570","volume":"24","author":"UG de Vasconcelos Cunha","year":"2007","unstructured":"de Vasconcelos Cunha UG, Lopes Rocha F, Avila de Melo R, Alves Valle E, de Souza Neto JJ, Mendes Brega R, et al. A placebo-controlled double-blind randomized study of venlafaxine in the treatment of depression in dementia. Dement Geriatr Cogn Disord. 2007;24:36\u201341.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1047_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1176\/ajp.146.1.45","volume":"146","author":"BV Reifler","year":"1989","unstructured":"Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, et al. Double-blind trial of imipramine in Alzheimer\u2019s disease patients with and without depression. Am J Psychiatry. 1989;146:45\u20139.","journal-title":"Am J Psychiatry"},{"key":"1047_CR28","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/mp.2013.20","volume":"18","author":"WD Taylor","year":"2013","unstructured":"Taylor WD, Aizenstein HJ, Alexopoulos GS. The vascular depression hypothesis: mechanisms linking vascular disease with depression. Mol Psychiatry. 2013;18:963\u201374.","journal-title":"Mol Psychiatry"},{"key":"1047_CR29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/archpsyc.1997.01830220033006","volume":"54","author":"GS Alexopoulos","year":"1997","unstructured":"Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. \u201cVascular depression\u201d hypothesis. Arch Gen Psychiatry. 1997;54:915\u201322.","journal-title":"Arch Gen Psychiatry"},{"key":"1047_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/nyas.12669","volume":"1345","author":"SS Morimoto","year":"2015","unstructured":"Morimoto SS, Kanellopoulos D, Manning KJ, Alexopoulos GS. Diagnosis and treatment of depression and cognitive impairment in late-life. Ann N Y Acad Sci. 2015;1345:36\u201346.","journal-title":"Ann N Y Acad Sci"},{"key":"1047_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/archgenpsychiatry.2010.184","volume":"68","author":"CF Reynolds","year":"2011","unstructured":"Reynolds CF, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH, et al. Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry. 2011;68:51\u201360.","journal-title":"Arch Gen Psychiatry"},{"key":"1047_CR32","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1192\/bjp.bp.113.140087","volume":"206","author":"A Spector","year":"2015","unstructured":"Spector A, Charlesworth G, King M, Lattimer M, Sadek S, Marston L, et al. Cognitive-behavioural therapy for anxiety in dementia: pilot randomised controlled trial. Br J Psychiatry. 2015;206:509\u201316.","journal-title":"Br J Psychiatry"},{"key":"1047_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.4088\/JCP.10m05973gry","volume":"72","author":"L Hausner","year":"2011","unstructured":"Hausner L, Damian M, Sartorius A, Frolich L. Efficacy and cognitive side effects of electroconvulsive therapy (ECT) in depressed elderly inpatients with coexisting mild cognitive impairment or dementia. J Clin Psychiatry. 2011;72:91\u20137.","journal-title":"J Clin Psychiatry"},{"key":"1047_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1479-8301.2009.00292.x","volume":"9","author":"S Takahashi","year":"2009","unstructured":"Takahashi S, Mizukami K, Yasuno F, Asada T. Depression associated with dementia with Lewy bodies (DLB) and the effect of somatotherapy. J Japanese Psychogeriatric Society. 2009;9:56\u201361.","journal-title":"J Japanese Psychogeriatric Society"},{"key":"1047_CR35","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/13854046.2015.1050457","volume":"29","author":"GS Dybedal","year":"2015","unstructured":"Dybedal GS, Tanum L, Sundet K, Bjolseth TM. The role of baseline cognitive function in the neurocognitive effects of electroconvulsive therapy in depressed elderly patients. Clin Neuropsychol. 2015;29:487\u2013508.","journal-title":"Clin Neuropsychol"},{"key":"1047_CR36","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jagp.2017.09.002","volume":"26","author":"IP Ilieva","year":"2018","unstructured":"Ilieva IP, Alexopoulos GS, Dubin MJ, Morimoto SS, Victoria LW, Gunning FM. Age-related repetitive transcranial magnetic stimulation effects on executive function in depression: a systematic review. Am J Geriatr Psychiatry. 2018;26:334\u201346.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1047_CR37","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1038\/s41386-018-0121-x","volume":"43","author":"TS Kaster","year":"2018","unstructured":"Kaster TS, Daskalakis ZJ, Noda Y, Knyahnytska Y, Downar J, Rajji TK, et al. Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial. Neuropsychopharmacology. 2018;43:2231\u20138.","journal-title":"Neuropsychopharmacology."},{"key":"1047_CR38","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/gps.5091","volume":"34","author":"AP Trevizol","year":"2019","unstructured":"Trevizol AP, Goldberger KW, Mulsant BH, Rajji TK, Downar J, Daskalakis ZJ, et al. Unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant late-life depression. Int J Geriatr Psychiatry. 2019;34:822\u20137.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1047_CR39","volume-title":"Psychometric theory","author":"J Nunnally","year":"1994","unstructured":"Nunnally J, Bernstein IH. Psychometric theory. New York, NY: McGraw Hill; 1994."},{"key":"1047_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/JGP.0b013e3181c796eb","volume":"18","author":"PB Rosenberg","year":"2010","unstructured":"Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, et al. Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry. 2010;18:136\u201345.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1047_CR41","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/JGP.0b013e3181cc0333","volume":"18","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, et al. Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes. Am J Geriatr Psychiatry. 2010;18:332\u201340.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1047_CR42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/JGP.0b013e318165dbae","volume":"16","author":"E Teng","year":"2008","unstructured":"Teng E, Ringman JM, Ross LK, Mulnard RA, Dick MB, Bartzokis G, et al. Diagnosing depression in Alzheimer disease with the National Institute of Mental Health provisional criteria. Am J Geriatr Psychiatry. 2008;16:469\u201377.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1047_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1047_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"key":"1047_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1300\/J018v05n01_09","volume":"5","author":"JI Sheikh","year":"1986","unstructured":"Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol: J Aging Mental Health. 1986;5:165\u201373.","journal-title":"Clin Gerontol: J Aging Mental Health"},{"key":"1047_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","volume":"23","author":"GS Alexopoulos","year":"1988","unstructured":"Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell scale for depression in dementia. Biol Psychiatry. 1988;23:271\u201384.","journal-title":"Biol Psychiatry"},{"key":"1047_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/JGP.0b013e31818b4111","volume":"17","author":"R Leontjevas","year":"2009","unstructured":"Leontjevas R, van Hooren S, Mulders A. The Montgomery-Asberg depression rating scale and the Cornell scale for depression in dementia: a validation study with patients exhibiting early-onset dementia. Am J Geriatr Psychiatry. 2009;17:56\u201364.","journal-title":"Am J Geriatr Psychiatry"},{"key":"1047_CR48","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/JGP.0b013e318233152b","volume":"20","author":"R Leontjevas","year":"2012","unstructured":"Leontjevas R, Gerritsen DL, Vernooij-Dassen MJFJ, Smalbrugge M, Koopmans RTCM. Comparative validation of proxy-based Montgomery-\u00c5sberg depression rating scale and Cornell scale for depression in dementia in nursing home residents with dementia. Am J Geriatr Psychiatry. 2012;20:985\u201393.","journal-title":"Am J Geriatr Psychiatry"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-019-1047-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-019-1047-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-019-1047-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T23:32:18Z","timestamp":1593819138000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-019-1047-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,5]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1047"],"URL":"https:\/\/doi.org\/10.1007\/s11920-019-1047-7","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,5]]},"assertion":[{"value":"5 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Kathleen S. Bingham has no disclosures.Alastair J. Flint currently receives grant support from the U.S. National Institutes of Health, the Patient-Centered Outcomes Research Institute, the Canadian Institutes of Health Research, Brain Canada, the Alzheimer\u2019s Association, and AGE-WELL.Benoit H. Mulsant<b>,<\/b> during the past 5\u00a0years, has received: research funding from Brain Canada, the CAMH Foundation, the Canadian Institutes of Health Research, and the US National Institutes of Health (NIH); research support from Bristol-Myers Squibb (medications for a NIH-funded clinical trial), Eli-Lilly (medications for a NIH-funded clinical trial), Pfizer (medications for a NIH-funded clinical trial), Capital Solution Design LLC (software used in a study funded by CAMH Foundation), and HAPPYneuron (software used in a study funded by Brain Canada). He directly own stocks of General Electric (less than $5000).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"74"}}